Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Development of ligands for in vivo imaging of cerebral nicotinic receptors.

Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED.

Behav Brain Res. 2000 Aug;113(1-2):143-57. Review.

PMID:
10942041
2.

Nicotinic acetylcholine receptors and imaging.

Gündisch D.

Curr Pharm Des. 2000 Jul;6(11):1143-57. Review.

PMID:
10903387
3.

Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain.

Sihver W, Långström B, Nordberg A.

Acta Neurol Scand Suppl. 2000;176:27-33. Review.

PMID:
11261802
4.

[Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].

Miyata H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Aug;28(4):149-58. Review. Japanese.

PMID:
18800618
5.

Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.

Newhouse PA, Kelton M.

Pharm Acta Helv. 2000 Mar;74(2-3):91-101. Review.

PMID:
10812945
6.

Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging.

Liu Y, Yu H, Zhao L, Zhang H.

Nucl Med Biol. 2013 Jan;40(1):126-34. doi: 10.1016/j.nucmedbio.2012.09.005. Epub 2012 Oct 26.

PMID:
23102538
7.
8.

The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration.

O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S.

Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):399-411. Review.

PMID:
12769612
9.

Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog.

Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN Jr, Dannals RF.

J Nucl Med. 1997 Nov;38(11):1737-41.

10.

Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging.

Hellström-Lindahl E, Court JA.

Behav Brain Res. 2000 Aug;113(1-2):159-68.

PMID:
10942042
11.

Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.

Mihailescu S, Drucker-Colín R.

Arch Med Res. 2000 Mar-Apr;31(2):131-44. Review.

PMID:
10880717
12.

[125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors.

Musachio JL, Villemagne VL, Scheffel U, Stathis M, Finley P, Horti A, London ED, Dannals RF.

Synapse. 1997 Aug;26(4):392-9.

PMID:
9215598
13.
14.

Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.

Doll F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C.

J Med Chem. 1999 Jun 17;42(12):2251-9.

PMID:
10377231
15.
16.

Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.

Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ.

Mol Pharmacol. 2006 Oct;70(4):1454-60. Epub 2006 Jul 20.

17.

N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.

Wilkins LH Jr, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.

J Pharmacol Exp Ther. 2003 Jan;304(1):400-10.

18.

Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.

Saji H, Watanabe A, Magata Y, Ohmomo Y, Kiyono Y, Yamada Y, Iida Y, Yonekura Y, Konishi J, Yokoyama A.

Chem Pharm Bull (Tokyo). 1997 Feb;45(2):284-90.

PMID:
9118442
19.

Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.

Hussmann GP, Turner JR, Lomazzo E, Venkatesh R, Cousins V, Xiao Y, Yasuda RP, Wolfe BB, Perry DC, Rezvani AH, Levin ED, Blendy JA, Kellar KJ.

J Pharmacol Exp Ther. 2012 Nov;343(2):441-50. doi: 10.1124/jpet.112.198085. Epub 2012 Aug 16.

20.

Fluorine-18-FPH for PET imaging of nicotinic acetylcholine receptors.

Horti A, Scheffel U, Stathis M, Finley P, Ravert HT, London ED, Dannals RF.

J Nucl Med. 1997 Aug;38(8):1260-5.

Supplemental Content

Support Center